全文获取类型
收费全文 | 317613篇 |
免费 | 18514篇 |
国内免费 | 541篇 |
专业分类
耳鼻咽喉 | 4405篇 |
儿科学 | 10852篇 |
妇产科学 | 10787篇 |
基础医学 | 48327篇 |
口腔科学 | 7811篇 |
临床医学 | 25906篇 |
内科学 | 61197篇 |
皮肤病学 | 6857篇 |
神经病学 | 23311篇 |
特种医学 | 12063篇 |
外国民族医学 | 43篇 |
外科学 | 48561篇 |
综合类 | 7845篇 |
现状与发展 | 1篇 |
一般理论 | 171篇 |
预防医学 | 21550篇 |
眼科学 | 7374篇 |
药学 | 22361篇 |
中国医学 | 840篇 |
肿瘤学 | 16406篇 |
出版年
2021年 | 3173篇 |
2019年 | 3001篇 |
2018年 | 4397篇 |
2017年 | 3254篇 |
2016年 | 3755篇 |
2015年 | 4212篇 |
2014年 | 5570篇 |
2013年 | 8351篇 |
2012年 | 10824篇 |
2011年 | 11264篇 |
2010年 | 7137篇 |
2009年 | 6460篇 |
2008年 | 10085篇 |
2007年 | 10946篇 |
2006年 | 10679篇 |
2005年 | 10188篇 |
2004年 | 9713篇 |
2003年 | 9132篇 |
2002年 | 8577篇 |
2001年 | 13404篇 |
2000年 | 13699篇 |
1999年 | 11525篇 |
1998年 | 3170篇 |
1997年 | 2898篇 |
1996年 | 2718篇 |
1995年 | 2621篇 |
1994年 | 2390篇 |
1992年 | 8345篇 |
1991年 | 8471篇 |
1990年 | 8279篇 |
1989年 | 8098篇 |
1988年 | 7331篇 |
1987年 | 7088篇 |
1986年 | 6736篇 |
1985年 | 6528篇 |
1984年 | 4769篇 |
1983年 | 4132篇 |
1982年 | 2482篇 |
1979年 | 4428篇 |
1978年 | 3235篇 |
1977年 | 2737篇 |
1976年 | 2507篇 |
1975年 | 2840篇 |
1974年 | 3358篇 |
1973年 | 3364篇 |
1972年 | 3122篇 |
1971年 | 2957篇 |
1970年 | 2841篇 |
1969年 | 2585篇 |
1968年 | 2541篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
A case of Rubinstein‐Taybi syndrome associated with growth hormone deficiency in childhood 下载免费PDF全文
3.
O. Ieromina C. J. M. Musters P. M. Bodegom W. J. G. M. Peijnenburg M. G. Vijver 《Ecotoxicology (London, England)》2016,25(6):1170-1180
Analyzing functional species’ characteristics (species traits) that represent physiological, life history and morphological characteristics of species help understanding the impacts of various stressors on aquatic communities at field conditions. This research aimed to study the combined effects of pesticides and other environmental factors (temperature, dissolved oxygen, dissolved organic carbon, floating macrophytes cover, phosphate, nitrite, and nitrate) on the trait modality distribution of aquatic macrofauna communities. To this purpose, a field inventory was performed in a flower bulb growing area of the Netherlands with significant variation in pesticides pressures. Macrofauna community composition, water chemistry parameters and pesticide concentrations in ditches next to flower bulb fields were determined. Trait modalities of nine traits (feeding mode, respiration mode, locomotion type, resistance form, reproduction mode, life stage, voltinism, saprobity, maximum body size) likely to indicate pesticides impacts were analyzed. According to a redundancy analysis, phosphate -and not pesticides- constituted the main factor structuring the trait modality distribution of aquatic macrofauna. The functional composition could be ascribed for 2–4 % to pesticides, and for 3–11 % to phosphate. The lack of trait responses to pesticides may indicate that species may have used alternative strategies to adapt to ambient pesticides stress. Biomass of animals exhibiting trait modalities related to feeding by predation and grazing, presence of diapause form or dormancy, reproduction by free clutches and ovoviviparity, life stage of larvae and pupa, was negatively correlated to the concentration of phosphate. Hence, despite the high pesticide pollution in the area, variation in nutrient-related stressors seems to be the dominant driver of the functional composition of aquatic macrofauna assembly in agricultural ditches. 相似文献
4.
5.
6.
Zaida Araujo Sietze Brandes Elena Pinelli María A. Bochichio Andrea Palacios Albina Wide Bruno Rivas-Santiago Juan Carlos Jiménez 《Revista do Instituto de Medicina Tropical de S?o Paulo》2015,57(1):47-55
The present study aimed at measuring seropositivities for infection by
Ascaris suum and Toxocara canis using the
excretory/secretory (E/S) antigens from Ascaris suum (AES) and
Toxocara canis (TES) within an indigenous population. In
addition, quantification of cytokine expressions in peripheral blood cells was
determined. A total of 50 Warao indigenous were included; of which 43 were adults and
seven children. In adults, 44.1% were seropositive for both parasites; whereas
children had only seropositivity to one or the other helminth. For ascariosis, the
percentage of AES seropositivity in adults and children was high; 23.3% and 57.1%,
respectively. While that for toxocariosis, the percentage of TES seropositivity in
adults and children was low; 9.3% and 14.3%, respectively. The percentage of
seronegativity was comparable for AES and TES antigens in adults (27.9%) and children
(28.6%). When positive sera were analyzed by Western blotting technique using AES
antigens; three bands of 97.2, 193.6 and 200.2 kDas were mostly recognized. When the
TES antigens were used, nine major bands were mostly identified; 47.4, 52.2, 84.9,
98.2, 119.1, 131.3, 175.6, 184.4 and 193.6 kDas. Stool examinations showed that
Blastocystis hominis, Hymenolepis nana and
Entamoeba coli were the most commonly observed intestinal
parasites. Quantification of cytokines IFN-γ, IL-2, IL-6, TGF-β, TNF-α, IL-10 and
IL-4 expressions showed that there was only a significant increased expression of
IL-4 in indigenous with TES seropositivity (p < 0.002).
Ascaris and Toxocara seropositivity was
prevalent among Warao indigenous. 相似文献
7.
8.
Edward J. Holland Walter O. Whitley Kenneth Sall Stephen S. Lane Aparna Raychaudhuri Steven Y. Zhang 《Current medical research and opinion》2016,32(10):1759-1765
Objective: Report efficacy findings from three clinical trials (one phase 2 and two phase 3 [OPUS-1, OPUS-2]) of lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease (DED).Research design and methods: Three 84-day, randomized, double-masked, placebo-controlled trials. Adults (≥18 years) with DED were randomized (1:1) to lifitegrast 5.0% or matching placebo. Changes from baseline to day 84 in signs and symptoms of DED were analyzed.Main outcome measures: Phase 2, pre-specified endpoint: inferior corneal staining score (ICSS; 0–4); OPUS-1, coprimary endpoints: ICSS and visual-related function subscale (0–4 scale); OPUS-2, coprimary endpoints: ICSS and eye dryness score (EDS, VAS; 0–100).Results: Fifty-eight participants were randomized to lifitegrast 5.0% and 58 to placebo in the phase 2 trial; 293 to lifitegrast and 295 to placebo in OPUS-1; 358 to lifitegrast and 360 to placebo in OPUS-2. In participants with mild-to-moderate baseline DED symptomatology, lifitegrast improved ICSS versus placebo in the phase 2 study (treatment effect, 0.35; 95% CI, 0.05–0.65; p?=?0.0209) and OPUS-1 (effect, 0.24; 95% CI, 0.10–0.38; p?=?0.0007). Among more symptomatic participants (baseline EDS ≥40, recent artificial tear use), lifitegrast improved EDS versus placebo in a post hoc analysis of OPUS-1 (effect, 13.34; 95% CI, 2.35–24.33; nominal p?=?0.0178) and in OPUS-2 (effect, 12.61; 95% CI, 8.51–16.70; p?<?0.0001).Limitations: Trials were conducted over 12 weeks; efficacy beyond this period was not assessed.Conclusions: Across three trials, lifitegrast improved ICSS in participants with mild-to-moderate baseline symptomatology in two studies, and EDS in participants with moderate-to-severe baseline symptomatology in two studies. Based on the overall findings from these trials, lifitegrast shows promise as a new treatment option for signs and symptoms of DED. 相似文献
9.
10.